Those with eczema who produce immunoglobulin E in response to environmental allergens are more likely to experience chronic and acute itching.
Researchers have successfully blocked an immune system protein with an antibody to stop itching associated with poison ivy contact.
Researchers investigated how the nervous system interacts with the immune system to cause the inflammation and itching associated with eczema. The findings could lead to new treatment options for eczema sufferers.
According to researchers, socially contagious itching may be hard wired in the brain.
Researchers implicate the neuropeptide NPPB in generating the itching sensation symptomatic of eczema.